Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: A preliminary study

Aging Male

Volumn 5, Issue 1, 2002, Pages 47-51

  Li, J Y ^a   Zhu, J C ^a   Dou, J T ^a   Bai, W J ^a   Deng, S M ^a   Li, M ^a   Huang, W ^a   Jin, H ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Androgen supplementation; Partial androgen deficiency in the aging male; Testosterone undecanoate

Indexed keywords

ALBUMIN; ANDROGEN; CHOLESTEROL; FOLLITROPIN; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTICLE; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE; SYMPTOM; TREATMENT OUTCOME;

EID: 0036267361     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.1080/tam.5.1.47.51     Document Type: Article

References (12)

1. The male climacteric
2. A critical evaluation of simple methods for the estimation of free testosterone in serum
3. Loss of circadian rhythmicity in blood testosterone levels with aging in normal man
4. Potentially predictive and manipulable blood serum correlates of aging in the healthy male: Progressive decrease in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin like growth factor 1 to growth hormone
5. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study
6. Male menopause
7. Validation of a screening questionnaire for androgen deficiency in aging male (ADAM)
8. A new 'aging males' symptoms' rating scale
9. Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency
10. The age-related decline of androgen levels in men: Clinically significant?
11. The association between hypotestosteronemia and coronary artery disease in men
12. A ten-year safety study of the oral androgen testosterone undecanoate